PET/Computed Tomography in Renal, Bladder, and Testicular Cancer

被引：19

作者：

Bouchelouche, Kirsten ^{[1
,2
]}

Choyke, Peter L. ^{[3
]}

机构：

[1] Aarhus Univ Hosp, Dept Nucl Med, Skejby,Brendstrupgaardsvej 100, DK-8200 Aarhus, Denmark

[2] Aarhus Univ Hosp, PET Ctr, DK-8200 Aarhus, Denmark

[3] NCI, Ctr Canc Res, Mol Imaging Program, Bethesda, MD 20892 USA

来源：

PET CLINICS | 2015年 / 10卷 / 03期

关键词：

PET/CT; Renal cancer; Bladder cancer; Testicular cancer;

D O I：

10.1016/j.cpet.2015.03.002

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

FDG PET/CT has no role in primary evaluation of a scrotal mass, but can be used for staging in GCT. However, FDG PET is not yet included in the international guidelines for staging of testicular cancer. For detection of residual disease, FDG PET/CT is an accurate diagnostic method in the postchemotherapy management of patients with seminoma.

引用

页码：361 / 374

页数：14

共 82 条

[1]

Ahlstrom H, 1996, ACTA RADIOL, V37, P180

[2]

Albers P, 2012, ACTAS UROL ESP, V36, P127, DOI [10.1016/j.acuroe.2012.05.002, 10.1016/j.acuro.2011.06.017]

[3] 18F-FDG PET/CT impact on testicular tumours clinical management [J].

Ambrosini, Valentina ;

Zucchini, Giorgia ;

Nicolini, Silvia ;

Berselli, Annalisa ;

Nanni, Cristina ;

Allegri, Vincenzo ;

Martoni, Andrea ;

Domenico, Rubello ;

Cricca, Antonia ;

Fanti, Stefano .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (04) :668-673

[4] Radiological evaluation of response to treatment: Application to metastatic renal cancers receiving anti-angiogenic treatment [J].

Ammari, S. ;

Thiam, R. ;

Cuenod, C. A. ;

Oudard, S. ;

Hernigou, A. ;

Grataloup, C. ;

Siauve, N. ;

Medioni, J. ;

Fournier, L. S. .

DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2014, 95 (06) :527-539

[5] 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer [J].

Anjos, Dalton A. ;

Etchebehere, Elba C. S. C. ;

Ramos, Celso D. ;

Santos, Allan O. ;

Albertotti, Csar ;

Camargo, Edwaldo E. .

JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (05) :764-770

[6] Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer [J].

Apolo, Andrea B. ;

Riches, Jamie ;

Schoeder, Heiko ;

Akin, Oguz ;

Trout, Alisa ;

Milowsky, Matthew I. ;

Bajorin, Dean F. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) :3973-3978

[7] Is The Value of FDG PET/CT In Evaluating Renal Metastasis Underestimated? A Case Report And Review of The Literature [J].

Aras, Mustafa ;

Dede, Fuat ;

Ones, Tunc ;

Inanir, Sabahat ;

Erdil, Tanju Yusuf ;

Turoglu, Halil Turgut .

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2013, 22 (03) :109-111

[8] 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial [J].

Bachner, M. ;

Loriot, Y. ;

Gross-Goupil, M. ;

Zucali, P. A. ;

Horwich, A. ;

Germa-Lluch, J. -R. ;

Kollmannsberger, C. ;

Stoiber, F. ;

Flechon, A. ;

Oechsle, K. ;

Gillessen, S. ;

Oldenburg, J. ;

Cohn-Cedermark, G. ;

Daugaard, G. ;

Morelli, F. ;

Sella, A. ;

Harland, S. ;

Kerst, M. ;

Gampe, J. ;

Dittrich, C. ;

Fizazi, K. ;

De Santis, M. .

ANNALS OF ONCOLOGY, 2012, 23 (01) :59-64

[9] Lymph node staging for urinary bladder carcinoma with positron emission tomography (PET) [J].

Bachor, R ;

Kotzerke, J ;

Reske, SN ;

Hautmann, R .

UROLOGE-AUSGABE A, 1999, 38 (01) :46-50

[10] FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals [J].

Becherer, A ;

De Santis, M ;

Karanikas, G ;

Szabó, M ;

Bokemeyer, C ;

Dohmen, BM ;

Pont, J ;

Dudczak, R ;

Dittrich, C ;

Kletter, K .

EUROPEAN JOURNAL OF RADIOLOGY, 2005, 54 (02) :284-288

← 1 2 3 4 5 6 7 8 9 →